Plexus
PLXS
266.57
-6.06
-2.22%
Plexus
US · PLXS
#1741 by market cap
Listed 1970
266.57
-6.06
-2.22%
Live - 5344 symbols - heartbeat 126s ago
· 2026-10-08 08:40
Pre-market
264.39
-0.82%
After-hours
266.57
0.00%
- Market cap
- 7.10B
- P/E (TTM)i
- 39.38
- P/Bi
- 4.65
- EPSi
- 6.26
- Div yieldi
- 0.00%
- 52W posi
- 77%
Reader sentiment
Are you bullish or bearish on PLXS?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 5.26, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +1.82% YoY
Margins
- Gross margin
- 10.08%
- Operating margin
- 5.13%
- Net margin
- 4.29%
Key ratios & quality
- Enterprise valuei
- 6.94B
- PEG ratioi
- 5.09
- Altman Z-Scorei
- 5.26
PEG uses trailing P/E against the 3-year net income growth rate (7.74%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.87B | 3.16B | 3.39B | 3.37B | 3.81B | 4.21B | 3.96B | 4.03B |
| Gross profit | 257.60M | 291.84M | 312.71M | 323.30M | 347.23M | 394.55M | 378.53M | 406.51M |
| Selling & admin expenses | 139.32M | 148.11M | 153.33M | 143.76M | 167.02M | 175.64M | 190.54M | 199.46M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 118.28M | 143.73M | 159.38M | 179.54M | 180.21M | 218.91M | 187.99M | 207.05M |
| Pretax profit | 107.61M | 125.96M | 135.40M | 160.41M | 158.30M | 161.01M | 129.53M | 188.02M |
| Tax | 94.57M | 17.34M | 17.92M | 21.50M | 20.06M | 21.92M | 17.72M | 15.13M |
| Net profit | 13.04M | 108.62M | 117.48M | 138.91M | 138.24M | 139.09M | 111.82M | 172.89M |
| Basic EPS | 0 | 4 | 4 | 5 | 5 | 5 | 4 | 6 |
| Diluted EPS | 0.38 | 3.50 | 3.93 | 4.76 | 4.86 | 4.95 | 4.01 | 6.26 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Revenue | 980.17M | 1.02B | 1.06B | 1.07B | 1.16B | 1.30B |
| Gross profit | 97.75M | 103.29M | 104.78M | 106.14M | 119.18M | 131.38M |
| Selling & admin expenses | 48.96M | 49.68M | 51.67M | 51.67M | 57.34M | 70.12M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 48.79M | 53.61M | 53.11M | 54.46M | 61.84M | 61.26M |
| Pretax profit | 45.02M | 49.84M | 49.67M | 51.03M | 57.88M | 56.45M |
| Tax | 5.95M | 4.72M | -1.76M | 9.85M | 8.07M | 13.46M |
| Net profit | 39.07M | 45.12M | 51.43M | 41.18M | 49.81M | 42.99M |
| Basic EPS | 1 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.41 | 1.64 | 1.87 | 1.51 | 1.82 | 1.58 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 1.52B | 1.54B | 1.78B | 1.93B | 2.82B | 2.67B | 2.48B | 2.40B |
| Cash & ST investments | 297.27M | 223.76M | 385.81M | 270.17M | 274.81M | 256.23M | 345.11M | 306.46M |
| Inventory | 794.35M | 700.94M | 763.46M | 972.31M | 1.60B | 1.56B | 1.31B | 1.23B |
| Total assets | 1.93B | 2.00B | 2.29B | 2.46B | 3.39B | 3.32B | 3.15B | 3.14B |
| Total current liabilities | 737.67M | 865.50M | 1.00B | 1.13B | 2.01B | 1.81B | 1.64B | 1.52B |
| Short-term debt | 5.53M | 100.70M | 146.83M | 66.31M | 273.97M | 240.21M | 157.33M | 45.79M |
| Long-term debt | 183.09M | 187.28M | 187.98M | 187.03M | 187.78M | 190.85M | 89.99M | 91.99M |
| Total liabilities | 1,011,499,000.00 | 1,135,307,000.00 | 1,312,368,000.00 | 1,433,661,000.00 | 2,297,494,000.00 | 2,106,790,000.00 | 1,828,996,000.00 | 1,682,522,000.00 |
| Total equity | 921.14M | 865.58M | 977.48M | 1.03B | 1.10B | 1.21B | 1.32B | 1.45B |
| Retained earnings | 1.06B | 1.18B | 1.30B | 1.43B | 1.57B | 1.71B | 1.82B | 2.00B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Total current assets | 2.40B | 2.40B | 2.40B | 2.46B | 2.64B | 2.90B |
| Cash & ST investments | 310.53M | 237.57M | 306.46M | 248.83M | 303.13M | 314.05M |
| Inventory | 1.28B | 1.28B | 1.23B | 1.31B | 1.37B | 1.49B |
| Total assets | 3.09B | 3.11B | 3.14B | 3.19B | 3.36B | 3.63B |
| Total current liabilities | 1.57B | 1.52B | 1.52B | 1.54B | 1.71B | 1.95B |
| Short-term debt | 121.01M | 50.68M | 45.79M | 66.84M | 143.11M | 183.81M |
| Long-term debt | 88.76M | 92.22M | 91.99M | 91.14M | 91.03M | 91.64M |
| Total liabilities | 1,734,065,000.00 | 1,686,548,000.00 | 1,682,522,000.00 | 1,704,904,000.00 | 1,871,169,000.00 | 2,104,845,000.00 |
| Total equity | 1.35B | 1.42B | 1.45B | 1.48B | 1.49B | 1.53B |
| Retained earnings | 1.90B | 1.94B | 2.00B | 2.04B | 2.09B | 2.13B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 66.83M | 115.30M | 210.37M | 142.58M | -26.24M | 165.82M | 436.50M | 249.23M |
| Depreciation & amortization | 48.30M | 52.21M | 56.69M | 61.01M | 62.69M | 69.76M | 77.85M | 77.79M |
| Free cash flow | 4.05M | 24.70M | 160.28M | 85.48M | -127.85M | 61.77M | 341.32M | 153.97M |
| Dividends paid | -- | -- | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -137.03M | -182.11M | -41.39M | -108.45M | -50.39M | -40.95M | -55.69M | -65.34M |
| Ending cash balance | 297.69M | 226.25M | 387.89M | 270.51M | 275.47M | 256.65M | 347.46M | 306.76M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| Operating cash flow | 36.69M | 26.88M | 132.02M | -15.38M | 28.46M | 25.91M |
| Depreciation & amortization | 19.52M | 19.58M | 19.28M | 19.24M | 19.26M | 18.86M |
| Free cash flow | 16.50M | 13.17M | 97.20M | -50.58M | 16.01M | -754.00K |
| Dividends paid | -- | -- | -- | -- | -- | -- |
| Stock buybacks / issuance | -12.54M | -18.44M | -21.53M | -22.39M | -21.04M | -20.63M |
| Ending cash balance | 310.56M | 237.62M | 306.76M | 249.42M | 303.18M | 314.57M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 1.34 | 12.16 | 12.75 | 13.85 | 13.02 | 12.04 | 8.81 | 12.44 |
| ROA %i | 0.67 | 5.52 | 5.48 | 5.85 | 4.72 | 4.14 | 3.45 | 5.50 |
| ROIC %i | 1.51 | 10.43 | 10.38 | 11.25 | 10.37 | 9.99 | 8.11 | 11.16 |
| 5-year avg ROE %i | 8.99 | 9.07 | 9.29 | 10.33 | 10.62 | 12.76 | 12.09 | 12.03 |
| EBIT margin %i | 4.17 | 4.39 | 4.47 | 5.18 | 4.57 | 4.57 | 4.00 | 4.95 |
| FCF / sales %i | 0.14 | 0.78 | 4.73 | 2.54 | -- | 1.47 | 8.62 | 3.82 |
| Current ratioi | 2.06 | 1.78 | 1.77 | 1.71 | 1.40 | 1.47 | 1.51 | 1.58 |
| Quick ratioi | 0.94 | 0.93 | 0.98 | 0.80 | 0.57 | 0.58 | 0.66 | 0.73 |
| Debt / assetsi | 9.76 | 14.39 | 16.23 | 11.83 | 14.60 | 14.14 | 8.87 | 5.33 |
| LT debt / equityi | 19.88 | 21.64 | 22.99 | 21.88 | 20.21 | 18.89 | 9.23 | 8.35 |
| Interest coveragei | 9.80 | 10.80 | 9.38 | 12.25 | 10.98 | 6.10 | 5.49 | 17.20 |
| Revenue CAGR (3Y) %i | 2.68 | 7.38 | 10.28 | 5.44 | 6.40 | 7.49 | 5.54 | 1.90 |
| Net income CAGR (3Y) %i | -48.29 | 12.43 | 1.59 | 120.03 | 8.37 | 5.79 | -6.98 | 7.74 |
| FCF CAGR (3Y) %i | -53.95 | -36.53 | 6.36 | 176.33 | -- | -27.23 | 58.65 | -- |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2026-01 | 2026-04 | 2026-07 |
|---|---|---|---|---|---|---|
| ROE %i | 10.93 | 12.12 | 12.44 | 12.63 | 13.20 | 12.58 |
| ROA %i | 4.49 | 5.18 | 5.50 | 5.65 | 5.82 | 5.50 |
| ROIC %i | 9.38 | 10.62 | 11.16 | 11.35 | 11.63 | 11.28 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 4.63 | 4.93 | 4.95 | 5.00 | 5.10 | 4.96 |
| FCF / sales %i | 8.86 | 6.23 | 3.82 | 1.85 | 1.76 | 1.35 |
| Current ratioi | 1.53 | 1.58 | 1.58 | 1.59 | 1.54 | 1.49 |
| Quick ratioi | 0.67 | 0.69 | 0.73 | 0.70 | 0.68 | 0.67 |
| Debt / assetsi | 7.86 | 5.61 | 5.33 | 5.82 | 7.73 | 8.24 |
| LT debt / equityi | 8.99 | 8.70 | 8.35 | 8.00 | 7.84 | 7.56 |
| Interest coveragei | 9.36 | 13.44 | 17.20 | 18.88 | 19.57 | 17.78 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
Revenue breakdown most recent period
Business
Single segment100.00%
Quote time 2026-10-08 08:40:13 · For reference only, not investment advice and not tailored to your situation.